Protagonist Therapeutics, Inc. (PTGX)
94.79
-0.56
(-0.59%)
USD |
NASDAQ |
Dec 15, 16:00
95.96
+1.17
(+1.23%)
After-Hours: 20:00
Protagonist Therapeutics Research and Development Expense (Annual): 138.13M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 17.26B |
| ADMA Biologics, Inc. | 1.813M |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Vanda Pharmaceuticals, Inc. | 74.43M |
| Bristol Myers Squibb Co. | 9.782B |